Hong-shuai Li
Chinese Academy Of Medical Sciences And Peking Union Medical College
Beijing, China
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Limited role of KRAS mutation in guiding immunotherapy in advanced non-small-cell lung cancer.
Journal: Future oncology (London, England)
Published: April 20, 2022
Dacomitinib for Advanced Non-small Cell Lung Cancer Patients Harboring Major Uncommon EGFR Alterations: A Dual-Center, Single-Arm, Ambispective Cohort Study in China.
Journal: Frontiers in pharmacology
Published: April 13, 2022
Efficacy and safety of concomitant immunotherapy and denosumab in patients with advanced non-small cell lung cancer carrying bone metastases: A retrospective chart review.
Journal: Frontiers in immunology
Published: March 30, 2022
Efficacy of dacomitinib in patients with non-small cell lung cancer carrying complex EGFR mutations: a real-world study.
Journal: Journal of thoracic disease
Published: November 22, 2021
A real-world study of dacomitinib in later-line settings for advanced non-small cell lung cancer patients harboring EGFR mutations.
Journal: Cancer medicine
Published: September 16, 2021
Remarkable response of BRAF V600E-mutated metastatic pancreatic cancer to BRAF/MEK inhibition: a case report.
Journal: Gastroenterology report
Published: February 24, 2021
Case Report: Dacomitinib May Not Benefit Patients Who Develop Rare Compound Mutations After Later-Line Osimertinib Treatment.
Journal: Frontiers in oncology
Published: January 13, 2021
Adenosquamous carcinoma of the digestive system: a literature review.
Journal: Scandinavian journal of gastroenterology
Published: October 19, 2020
Osimertinib for Chinese advanced non-small cell lung cancer patients harboring diverse EGFR exon 20 insertion mutations.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: August 08, 2020
Showing 1-12 of 12
Last Updated: 09/26/2026